These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 26863111)
21. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919 [TBL] [Abstract][Full Text] [Related]
22. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. McMahon K; Karumanchi SA; Stillman IE; Cummings P; Patton D; Easterling T Am J Obstet Gynecol; 2014 Jan; 210(1):68.e1-4. PubMed ID: 23994221 [TBL] [Abstract][Full Text] [Related]
23. [Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction]. Semczuk-Sikora A; Krzyzanowski A; Stachowicz N; Robak J; Kraczkowski J; Kwiatek M; Semczuk M Ginekol Pol; 2007 Oct; 78(10):783-6. PubMed ID: 18200969 [TBL] [Abstract][Full Text] [Related]
24. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes. Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584 [TBL] [Abstract][Full Text] [Related]
25. Assessment of serum levels and placental bed tissue expression of IGF-1, bFGF, and PLGF in patients with placenta previa complicated with placenta accreta spectrum disorders. Arakaza A; Liu X; Zhu J; Zou L J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2305264. PubMed ID: 38247274 [TBL] [Abstract][Full Text] [Related]
26. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195 [TBL] [Abstract][Full Text] [Related]
27. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772 [TBL] [Abstract][Full Text] [Related]
28. Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta. Oztas E; Ozler S; Ersoy AO; Ersoy E; Caglar AT; Uygur D; Yucel A; Ergin M; Danisman N Placenta; 2016 Mar; 39():1-6. PubMed ID: 26992667 [TBL] [Abstract][Full Text] [Related]
29. Circulating angiogenic factors and the risk of preeclampsia. Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923 [TBL] [Abstract][Full Text] [Related]
30. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia. Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430 [TBL] [Abstract][Full Text] [Related]
32. Maternal Serum VEGF Predicts Abnormally Invasive Placenta Better than NT-proBNP: a Multicenter Case-Control Study. Schwickert A; Chantraine F; Ehrlich L; Henrich W; Muallem MZ; Nonnenmacher A; Petit P; Weizsäcker K; Braun T Reprod Sci; 2021 Feb; 28(2):361-370. PubMed ID: 33025531 [TBL] [Abstract][Full Text] [Related]
33. Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880 [TBL] [Abstract][Full Text] [Related]
34. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Vatten LJ; Åsvold BO; Eskild A Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089 [TBL] [Abstract][Full Text] [Related]
35. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323 [TBL] [Abstract][Full Text] [Related]
36. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia. Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831 [TBL] [Abstract][Full Text] [Related]
37. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016 [TBL] [Abstract][Full Text] [Related]
38. Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester. Muller PR; James AH; Murtha AP; Yonish B; Jamison MG; Dekker G Hypertens Pregnancy; 2006; 25(3):183-92. PubMed ID: 17065039 [TBL] [Abstract][Full Text] [Related]
39. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795 [TBL] [Abstract][Full Text] [Related]